Sebi fines Sun Pharma Advanced Research's promoter entity Rs 3 lakh

The Securities and Exchange Board of India (Sebi), in its order, has imposed a penalty on Virtuous Share Investments 'which will be commensurate with the violation committed by it'.
Mumbai Market regulator Sebi today slapped a fine of Rs 300000 on Sun Pharma Advanced Research's promoter group entity for allegedly failing to make shareholding disclosures within stipulated timeline. The Securities and Exchange Board of India (Sebi), in its order, has imposed a penalty on Virtuous Share Investments "which will be commensurate with the violation committed by it". According to the regulator, pursuant to the rights issue, Sun Pharma Advanced Research Limited had allotted 16.500000 partly paid-up shares to Virtuous Share Investments on October 3, 2012. Consequently, shareholding of Virtuous Share Investments rose from 1.030000000 shares, amounting to 4.98% stake of Sun Pharma Advanced Research, to 1.190000000 scrips or 5.06% holding. The intimation of receipt of allotment was received by the promoter entity on October 10, 2012. Virtuous Share Investments was required to disclose its shareholding to the company within two days from the receipt of intimation of allotment of shares (by October 12, 2012). However, Sebi alleged the promoter group firm failed to make the disclosures within the prescribed timeline. "The disclosure...was made by the noticee (Virtuous Share Investments) with a delay of more than a month," Sebi said. As per norms, any person who holds more than five% shares or voting rights in any listed company, is required to disclose to the company the number of shares or voting rights held by such entity on becoming the holder within two working days of the receipt of allotment of shares or acquisition of shares or voting rights. PTI